NY-ESO-1-redirected T Cells

· Centre Hospitalier Universitaire Vaudois

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NY-ESO-1-redirected T Cells, covering 2025-04-20 to 2025-04-20. Get the full timeline:

Most recent: Clinical Trial Update: NY-ESO-1-redirected T Cells in Patients With Advanced Melanoma and Sarcoma [Phase 1]